These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23266721)

  • 1. The connection of β-catenin and phenobarbital in murine hepatocarcinogenesis: a critical discussion of Awuah et al., PLoS ONE 7(6):e39771, 2012.
    Braeuning A
    Arch Toxicol; 2013 Mar; 87(3):401-2. PubMed ID: 23266721
    [No Abstract]   [Full Text] [Related]  

  • 2. β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice.
    Awuah PK; Rhieu BH; Singh S; Misse A; Monga SP
    PLoS One; 2012; 7(6):e39771. PubMed ID: 22761897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
    Loeppen S; Schneider D; Gaunitz F; Gebhardt R; Kurek R; Buchmann A; Schwarz M
    Cancer Res; 2002 Oct; 62(20):5685-8. PubMed ID: 12384525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of hepatocarcinogenesis after single exposure of synchronized cells of the regenerating liver to N-nitrosodiethylamine and subsequent administration of phenobarbital].
    Osipova LA; Vinarchuk MP; Khranovskaia LN; Bykorez AI
    Eksp Onkol; 1987; 9(5):61-4. PubMed ID: 3691396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of Trianthema portulacastrum L. diethylnitroso-amine-induced phenobarbital promoted hepatocarcinogenesis.
    Bhattacharya S; Chatterjee M
    Neoplasma; 1999; 46(2):105-11. PubMed ID: 10466434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.
    Rignall B; Braeuning A; Buchmann A; Schwarz M
    Carcinogenesis; 2011 Jan; 32(1):52-7. PubMed ID: 21047994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenic risk assessment: are there dose thresholds for carcinogens?
    Fukushima S
    Asian Pac J Cancer Prev; 2010; 11(1):19-21. PubMed ID: 20593922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-catenin Mutations Are Not Involved in Early-stage Hepatocarcinogenesis Induced by Protoporphyrinogen Oxidase Inhibitors in Mice.
    Kuwata K; Inoue K; Ichimura R; Takahashi M; Kodama Y; Shibutani M; Yoshida M
    Toxicol Pathol; 2017 Jun; 45(4):493-505. PubMed ID: 28580885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
    Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
    Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. d-limonene chemoprevention of hepatocarcinogenesis in AKR mice: inhibition of c-jun and c-myc.
    Giri RK; Parija T; Das BR
    Oncol Rep; 1999; 6(5):1123-7. PubMed ID: 10425313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ploidy and specific karyotypic changes during promotion with phenobarbital, 2,5,2',5'-tetrachlorobiphenyl, and/or 3,4,3'4'-tetrachlorobiphenyl in rat liver.
    Sargent LM; Sattler GL; Roloff B; Xu YH; Sattler CA; Meisner L; Pitot HC
    Cancer Res; 1992 Feb; 52(4):955-62. PubMed ID: 1737357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis.
    Lee GH
    Toxicol Pathol; 2000; 28(2):215-25. PubMed ID: 10805139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence for chemopreventive potential of beta-carotene against experimental carcinogenesis: diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis is prevented more effectively by beta-carotene than by retinoic acid.
    Bishayee A; Sarkar A; Chatterjee M
    Nutr Cancer; 2000; 37(1):89-98. PubMed ID: 10965525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective poisoning of Ctnnb1-mutated hepatoma cells in mouse liver tumors by a single application of acetaminophen.
    Singh Y; Braeuning A; Schmid A; Pichler BJ; Schwarz M
    Arch Toxicol; 2013 Aug; 87(8):1595-607. PubMed ID: 23479080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.
    Braeuning A; Gavrilov A; Geissler M; Wenz C; Colnot S; Templin MF; Metzger U; Römer M; Zell A; Schwarz M
    Arch Toxicol; 2016 Jun; 90(6):1481-94. PubMed ID: 26838046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine.
    Williams GM; Iatropoulos MJ; Jeffrey AM
    Toxicol Pathol; 2000; 28(3):388-95. PubMed ID: 10862555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-alpha transgenic mice.
    Puatanachokchai R; Kakuni M; Wanibuchi H; Kinoshita A; Kang JS; Salim EI; Morimura K; Tamano S; Merlino GT; Fukushima S
    Asian Pac J Cancer Prev; 2006; 7(2):274-8. PubMed ID: 16839222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of membrane bound enzyme profiles by sodium selenite in N-nitrosodiethylamine induced and phenobarbital promoted hepatocarcinogenesis in rats.
    Thirunavukkarasu C; Sakthisekaran D
    Biomed Pharmacother; 2003; 57(3-4):117-23. PubMed ID: 12818472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid induction of preneoplastic liver foci in embryonal turkey liver by diethylnitrosamine.
    Enzmann H; Kühlem C; Kaliner G; Löser E; Bannasch P
    Toxicol Pathol; 1995; 23(5):560-9. PubMed ID: 8578099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dietary taurine supplementation on hepatic morphological changes of rats in diethylnitrosamine-induced hepatocarcinogenesis.
    Chang KJ; Yu CH; Son M
    Adv Exp Med Biol; 2003; 526():253-9. PubMed ID: 12908608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.